13028 Interurban Ave S Suite 124, Seattle, WA 98168
What We Treat / Addiction
Stimulant use disorder — whether involving methamphetamine, cocaine, or prescription stimulants — is a serious condition that responds to structured behavioral treatment. Mountain View Treatment provides expert outpatient care in Seattle.
Understanding
Addiction
Stimulant use disorder refers to problematic use of stimulant drugs — including methamphetamine, cocaine, crack cocaine, and prescription stimulants such as Adderall and Ritalin — resulting in significant impairment or distress. The defining pharmacological effect of stimulants is a powerful, rapid increase in dopamine release in the brain's reward circuits, creating intense euphoria followed by a prolonged crash.
Washington State has seen a significant rise in methamphetamine-related deaths in recent years, with meth now accounting for more overdose deaths in the state than any other drug. Unlike opioids, methamphetamine overdose deaths are not driven by accidental dosing — they reflect the cumulative cardiovascular and neurological damage of chronic use.
Unlike opioid use disorder, no FDA-approved pharmacotherapy for stimulant use disorder currently exists. Behavioral therapies — particularly contingency management and cognitive behavioral therapy — are the evidence-based cornerstones of treatment.
Warning Signs
Stimulant use disorder presents differently depending on the specific substance, but common clinical indicators include:
Binge-Crash Pattern
Using stimulants in runs or binges followed by prolonged sleep, depression, and fatigue.
Paranoia & Psychosis
Experiencing paranoid ideation, hallucinations, or psychotic symptoms during or after use — common with methamphetamine.
Cardiovascular Symptoms
Rapid heart rate, elevated blood pressure, chest pain, or irregular heartbeat associated with stimulant use.
Severe Mood Disturbance
Pronounced depression, irritability, anxiety, or emotional volatility between uses or during withdrawal.
Compulsive Use
Inability to stop using despite serious consequences including health deterioration, job loss, or relationship breakdown.
Social Isolation
Withdrawal from previously valued relationships and activities; keeping use secret or associating exclusively with other users.
Withdrawal & Detox
Stimulant withdrawal — sometimes called "the crash" — is not medically dangerous but is psychologically severe. The profound dopamine depletion following heavy stimulant use produces an extended period of depression, fatigue, and anhedonia that is a primary driver of relapse. Understanding this phase is critical to recovery.
Days 1–3
The Crash
Days 4–14
Withdrawal
Weeks to Months
Extended Recovery
Methamphetamine use causes measurable structural damage to dopamine-producing neurons that can take 12–18 months of abstinence to partially recover. This is why the anhedonia of early meth recovery can be so profound and prolonged — it is a genuine neurological deficit, not a character failing. Our clinical team provides evidence-based support through this extended adjustment period.
Our Approach
Because no medication has been approved for stimulant use disorder, behavioral therapies and structured programming carry even greater clinical weight. Mountain View's approach combines the highest-evidence behavioral treatments with holistic support.
(253)-252-5875Contingency Management
The most evidence-supported behavioral approach for stimulant use disorder. Positive reinforcement for drug-free urine screens and treatment attendance produces measurably better outcomes.
Cognitive Behavioral Therapy
CBT addresses the high-risk situations, thinking patterns, and behavioral triggers that sustain stimulant use and builds comprehensive relapse prevention skills.
Intensive Group Therapy
Daily structured groups provide peer accountability, process the shame associated with stimulant use, and build community support critical to early recovery.
Dual Diagnosis Treatment
Depression, ADHD, and trauma are highly prevalent in stimulant use disorder. Treating these concurrently dramatically improves recovery outcomes.
Psychosis & Psychiatric Support
Methamphetamine-associated psychosis requires clinical management. Our team coordinates psychiatric evaluation and medication management when indicated.
Dual Diagnosis
Stimulant use disorder has an exceptionally high rate of co-occurring psychiatric conditions — both as drivers of initial use and as consequences of prolonged stimulant exposure. These conditions require concurrent treatment for lasting recovery.
At Mountain View Treatment, psychiatric evaluation is integrated into the intake process. Co-occurring conditions are treated alongside stimulant use disorder — not sequentially — with an integrated team that includes addiction medicine, individual therapy, and psychiatric support when needed.
Stimulant-Induced Depression
The dopamine depletion of stimulant withdrawal produces severe, prolonged depression. Distinguishing stimulant-induced depression from primary major depressive disorder requires careful clinical assessment — the treatment implications differ significantly.
Stimulant-Induced Psychosis
Methamphetamine can induce psychotic symptoms — paranoid delusions, auditory and visual hallucinations — that are clinically indistinguishable from primary psychosis during the acute phase. These typically resolve with extended abstinence.
ADHD
ADHD is overrepresented in stimulant use disorder. Stimulants produce paradoxical calming in ADHD, and many individuals discover this effect accidentally or deliberately self-medicate. Proper ADHD treatment is essential.
PTSD & Trauma
Stimulants are frequently used to suppress hypervigilance and emotional numbing in PTSD, or conversely to avoid dissociative states. Trauma-focused therapy addresses these dynamics directly.
Bipolar Disorder
The manic-like states induced by stimulants can obscure underlying bipolar disorder, or stimulant use can destabilize existing bipolar cycling. Careful psychiatric assessment is required before mood stabilizer decisions are made.
Anxiety Disorders
Stimulant withdrawal produces intense anxiety and paranoia that frequently warrants clinical management. Underlying anxiety disorders may have pre-dated stimulant use and contributed to it.
Programs at Mountain View
Stimulant use disorder treatment is covered under the Mental Health Parity Act by most major PPO plans. We verify your benefits before you begin.
Partial Hospitalization Program (PHP)
Intensive daytime programming 5–6 hours per day while you return to supportive housing each evening. Ideal as a first step when full residential treatment isn't required.
Intensive Outpatient Program (IOP)
Approximately 9–12 structured hours per week, designed for individuals stepping down from PHP or whose lives allow continued work, school, or family engagement.
Outpatient Program (OP)
Flexible individual and group therapy scheduled around your routine — a critical long-term support structure for sustained recovery.
Why Mountain View Treatment
Contingency Management
We offer contingency management — the most evidence-based behavioral treatment for stimulant use disorder.
Insurance Accepted
Most major PPO plans cover stimulant use disorder treatment. We verify benefits before you begin.
Dual Diagnosis Capable
Depression, ADHD, trauma, and psychiatric comorbidities are treated alongside stimulant use disorder.
Confidential Care
HIPAA and 42 CFR Part 2 protections apply. Your treatment information remains entirely private.
Common Questions
No FDA-approved medication currently exists specifically for stimulant use disorder. Some medications (bupropion, modafinil) show modest evidence in research settings but are not standard of care. Behavioral therapies — especially contingency management — are the evidence-based first-line treatment.
Contingency management is a behavioral treatment that provides positive reinforcement (rewards) for drug-free urine screens and treatment engagement. It has the strongest evidence base of any behavioral intervention for stimulant use disorder. Yes, we incorporate contingency management in our programming.
Stimulant withdrawal, while psychologically difficult (depression, fatigue, dysphoria), is not medically dangerous and generally does not require supervised medical detox. Most clients can begin outpatient programming directly.
Methamphetamine-induced psychosis is a psychiatric emergency. If you or someone you know is experiencing paranoia, delusions, or hallucinations, seek emergency medical care. Once stabilized, our clinical team can coordinate a safe transition into outpatient treatment.
Stimulant use disorder often requires extended engagement — 12 weeks or more in IOP, followed by ongoing outpatient support. Early recovery from stimulants involves prolonged anhedonia (inability to feel pleasure) that resolves over months with appropriate support.
Financial Concierge
We believe that navigating the financial aspects of recovery should never be a barrier to care. We work intimately with most major PPO insurance providers to maximize your benefits and minimize out-of-pocket expenses.
How The Process Works
Secure Submission
Provide your basic policy info via our 100% HIPAA-compliant portal. Your data is strictly guarded.
Expert Analysis
Our financial advocates liaise directly with your provider to uncover the full extent of your coverage.
Clear Guidance
Within 1-2 hours, we present a completely transparent, commitment-free breakdown of your benefits.